ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $93,000 | -13.9% | 18,889 | -7.4% | 0.00% | -84.6% |
| Q2 2021 | $108,000 | +10.2% | 20,389 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $98,000 | +12.6% | 20,389 | +1.5% | 0.01% | +8.3% |
| Q4 2020 | $87,000 | -99.9% | 20,089 | -4.5% | 0.01% | -20.0% |
| Q3 2020 | $86,701,000 | +365.0% | 21,044 | +327.7% | 0.02% | +400.0% |
| Q4 2019 | $18,647,000 | +8299.5% | 4,920 | -60.7% | 0.00% | -93.3% |
| Q3 2018 | $222,000 | -45.5% | 12,530 | -20.5% | 0.04% | -40.8% |
| Q2 2018 | $407,000 | +10.6% | 15,770 | +2.4% | 0.08% | +5.6% |
| Q1 2018 | $368,000 | – | 15,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |